Skip to main content
. Author manuscript; available in PMC: 2024 Aug 1.
Published in final edited form as: Hepatology. 2023 Feb 22;78(2):578–591. doi: 10.1097/HEP.0000000000000313

Table 4.

Factors associated with NAFLD (CAP ≥263 dB/m) in univariate and multivariable analyses

Univariate analysis Multivariable analysis
Variables OR CI P-Value OR CI P-Value
Age 1.04 1.02-1.06 <0.01 1.04 1.01-1.08 0.02
Gender
Male Reference
Cisgender Female 1.71 0.96-3.07 0.97
Transgender female 0.91 0.40-2.06 0.96
Race
White Reference
Black 0.36 0.22-0.59 0.01 0.42 0.19-0.92 0.03
Other 0.60 0.28-1.33 0.98 0.52 0.14-1.87 0.31
Ethnicity
Hispanic or Latino 1.66 0.99-2.74 0.97
Non-Hispanic Reference
Study site
Indiana Reference
Massachusetts 1.91 1.10-3.31 0.02 2.42 0.92-6.39 0.08
Texas 1.93 1.12-3.33 0.02 3.35 1.31-8.60 0.01
Waist circumference, cm 1.10 1.08-1.13 <0.01 1.05 0.99-1.10 0.04
BMI 1.25 1.18-1.33 <0.01
Diabetes Mellitus
No Reference
Yes 3.30 1.50-7.29 <0.01 3.20 1.02-10.07 0.04
ALT 1.05 1.03-1.07 <0.01 1.05 1.01-1.08 0.01
AST 1.04 1.02-1.06 <0.01
Platelets 1.00 0.99-1.01 0.48
Triglycerides 1.01 1.00-1.01 <0.01
Fasting glucose 1.03 0.99-1.06 0.14
Insulin 1.05 1.02-1.08 <0.01
HOMA-IR 2.05 1.20-3.53 0.01
Current CD4 1.00 1.00-1.002 0.02
Nadir CD4 0.99 0.99-1.00 0.06
Current ART 3.25 0.86-12.25 0.08